It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

To determine whether increased androgen receptor protein concentration has a causal role in the hormone sensitive-to-hormone refractory ... LNCaP human prostate cancer cells.

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...

Jethro C.C. Kwong, a urology resident from the University of Toronto, discusses a novel artificial intelligence (AI)-based ...

Objectives This paper (1) sought to compare sleep, mood and physical symptom profiles of men with prostate cancer (PCa) who experienced subjective ... study examined 24 new patients with PCa receiving ...